Seldane Articles
US GENERIC DRUG MARKET TO 1995
17 February 1992
US OTC DRUGMAKERS A TAKEOVER TARGET
17 February 1992
RECORD 4TH QTR FROM US DRUG COMPANIES
10 February 1992
TOUGH TIMES AHEAD FOR MARION MERRELL DOW?
27 January 1992
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
